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Abstract: B a c k g r o u n d: In early phase of acute pancreatitis (AP), systemic infl ammatory response 
syndrome may lead to organ failure. Th e severe form of AP is associated with high mortality that may be 
prevented by timely diagnosis and treatment of the predicted severe cases. Serum interleukin 6 (IL-6) and 
urokinase-type plasminogen activator receptor (uPAR) have been proposed as accurate early markers of 
severe AP. Th e aim of the study was to assess whether widely available blood count indexes: neutrophil to 
lymphocyte (NLR), lymphocyte to monocyte (LMR) and platelet to lymphocyte ratios correlate with IL-6 
and uPAR and may be utilized to predict organ complications at the early phase of AP.
M e t h o d s: Th e study included 95 adult patients with AP treated at the Surgical Ward Complex of Health 
Care Centers in Wadowice, Poland. Organ failure was diagnosed according to modifi ed Marshall scoring 
system, as recommended by 2012 Atlanta classifi cation. Blood samples for laboratory tests were collected 
on days 1, 2 and 3 following the onset of AP symptoms.
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R e s u l t s: Patients with organ failure presented signifi cantly lower LMR on day 1 and signifi cantly higher 
NLR on days 2 and 3. Strong positive correlations between NLR and IL-6 and moderate correlations 
between NLR and uPAR were observed throughout the  study. Day 2 and 3 NLR values signifi cantly 
predicted organ failure at the early phase of AP.
C o n c l u s i o n s: Taking into account the wide availability of NLR, it may be considered as a surrogate 
of more expensive tests to help the early assessment of organ failure complicating AP.
Key words: urokinase- type plasminogen activator receptor, neutrophil-lymphocyte ratio, platelet-
-lymphocyte ratio, monocyte-lymphocyte ratio, persistent organ failure, interleukin 6.
Introduction
Acute pancreatitis (AP) is a  relatively common acute digestive tract disorder, which 
in nearly 80% of patients progresses mildly and without complications (mild acute 
pancreatitis, MAP), but in about 20% of cases it develops into the  severe form 
(severe acute pancreatitis, SAP) associated with nearly 20% mortality, reaching  50–80% 
in elderly patients or those with comorbidities such as chronic kidney disease, 
cardiovascular, autoimmunological disease or diabetes [1].
Th e medical advancement in imaging techniques witnessed in the  last decades 
and the  widespread availability of contrast-enhanced computed tomography, 
ultrasonography, and magnetic resonance have signifi cantly facilitated the diagnostic 
process of AP and contributed to the timely detection of early necrotic changes [1]. 
According to the  current Atlanta 2012 classifi cation [2], imaging fi ndings, beside 
typical symptoms and over threefold increase in pancreatic enzymes activity (amylase, 
lipase) are included in the diagnostic criteria for AP. Th e severity of AP in the revised 
2012 Atlanta classifications was based on organ failure and local and systemic 
complications [2]. Notably, vital organ (cardiovascular, pulmonary and renal) failure 
persistent over 48 hours has been underscored as the main cause of early mortality 
in AP [2].
A significant progress has also been observed in the  understanding of AP 
pathomechanism, in consequence of which a  range of diagnostic tools for early 
SAP prediction has been proposed. Th e evaluation of laboratory markers has led to 
the development of prognostic scores such as Ranson, Glasgow, APACHE II or BISAP. 
Moreover, single biomarkers have emerged, which may help in timely prognosis of 
severe course of AP [1, 3–6].
A continuous and consecutive clinical observation of AP patients has highlighted 
the  importance of the  “therapeutic window” estimated at the  fi rst 48 hours from 
AP onset when an accurate diagnosis and immediate treatment can directly impact 
patients’ survival. Th e most commonly used prognostic markers include acute phase 
proteins (C-reactive protein, albumin, fibrinogen), procalcitonin, total calcium 
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concentration, markers of renal function (urea, creatinine), coagulation parameters 
(D-dimers), white blood cell count and diff erential and recently also proinfl ammatory 
cytokine interleukin 6 (IL-6) [1, 3–6]. Recently, urokinase-type plasminogen activator 
receptor (uPAR) has also been suggested as an early prognostic marker of SAP [7].
Major prognostic scores — Ranson’s or Glasgow-Imire’s used in the fi rst 48 hours 
from AP onset as well as BISAP used in the  fi rst 24 hours — include total white 
blood cell (WBC) count [8]. Other blood cell counts, i.e. absolute neutrophil, 
lymphocytes, monocytes or platelet counts and indexes based on the  counts: 
neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) as well as 
lymphocyte to monocyte ratio (LMR) have not been as extensively used in day-to-day 
diagnostic process [1, 3–5, 9]. On the other hand, however, the review of literature on 
the  prognostic signifi cance of the  decreased lymphocyte counts and increased NLR 
or PLR points to their promising diagnostic utility in SAP prognosis [3, 6, 8–12]. 
Th e study by Cho et al. [3] found that higher NLR or PLR values can indicate systemic 
infl ammatory response syndrome (SIRS) and a risk of its developing into multi-organ 
dysfunction syndrome (MODS) [6, 13]. In 2017, Borges et al. [5] proposed Panc4, 
a  new prognostic model, which comprises urea and creatinine, but also indexes: 
neutrophil/leukocytes, platelet/leukocytes ratio and NLR. 
Th e aim of the study was to evaluate whether calculation of NLR, LMR and PLR on 
the fi rst three days of AP can aid the prognosis of severe course of the disease, associated 
with vital organ failure at the  early phase. Moreover, we assessed the  correlations 
between the NLR, LMR and PLR indexes and more sophisticated laboratory markers 
of infl ammation, including urokinase-type plasminogen activator receptor (uPAR) and 
IL-6 in serum over the fi rst 72 hours from the onset of AP symptoms. 
Materials and Methods
Th e study group included patients with AP diagnosis, treated at the  Surgical Ward 
Complex of Health Care Centers in Wadowice from March 2014 until December 2015. 
Th e  patients were included provided they were admitted within the  fi rst 24  hours 
from the  onset of AP symptoms. Th e  study group included solely adult patients 
with AP who provided their written voluntary consent to participate in the  study. 
Th e  exclusion criteria included liver, kidney disease, chronic pancreatitis or cancer 
at the  moment of recruitment. AP diagnosis and the  classifi cation of AP severity 
were based on the revised 2012 Atlanta classifi cation [2], according to which two out 
of the  three listed criteria must be met: typical abdominal pain, at least a  threefold 
increase in pancreatic enzymes’ activity and imaging fi ndings characteristic of 
AP (in computed tomography, ultrasonography or magnetic resonance imaging). 
Mild (MAP), moderately severe (MSAP) and severe (SAP) acute pancreatitis were 
distinguished based on the course of the disease.
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Organ failure during the fi rst week of AP was assessed according to the modifi ed 
Marshall scoring system (MMSS) [2]. The  Bioethics Committee of the  Beskidy 
Medical Chamber approved the study protocol (approval number 2014/02/06/1 issued 
on 6 February 2014).
Blood samples for laboratory tests were collected from the patients thrice: within 
the fi rst 24 hours from the onset of AP symptoms (day 1), and then on the following 
two days (day 2 and day 3). Th e routine tests (complete blood counts, serum amylase, 
alanine and aspartate transaminase, and lactate dehydrogenase activities, serum 
albumin, total protein, total calcium, glucose, urea, creatinine, bilirubin, procalcitonin 
and C-reactive protein concentrations, and plasma D-dimer concentrations) were 
conducted in the Diagnostic Laboratory in Wadowice. Complete blood counts were 
performed with automated hematologic analyzer Sysmex XN (Sysmex Corporation, 
Cobe, Japan). Based on the absolute counts of neutrophils, lymphocytes, monocytes 
and platelets, NLR, LMR, and PLR indexes were calculated. For the  assessment of 
routine biochemical and immunochemical tests, Cobas E411 (Roche Diagnostics, 
Mannheim, Germany) and Vitros 5600 (Ortho Clinical Diagnostics, Raritan, NJ, 
USA) were used, whereas the  coagulation tests were conducted with Coag XL 
(Diagno, Budapest, Hungary).
Moreover, the  aliquots of the  sera were used for the  measurements of IL-6 
and uPAR concentrations. IL-6 was measured in the  Diagnostics Department of 
University Hospital in Krakow by automatized electrochemiluminescence assay 
(ECLIA) on the  Cobas 8000 analyzer (Roche Diagnostics, Manheim, Germany). 
Th e measurements of uPAR were conducted at the Department of Diagnostics, Chair 
of Clinical Biochemistry at Jagiellonian University in Krakow using the  Quantikine 
Human uPAR Immunoassay reagent kits (R&D Systems, Minneapolis, USA). 
Th e  intraassay precision for the  test was ≤7.5% and the  interassay precision ≤5.6%, 
the  minimum detectable dose of uPAR was 0.033 ng/mL, while the  concentrations 
of uPAR in healthy volunteers were between 1.195 and 4.414 ng/mL as provided by 
the manufacturer of the kit. 
Statistical analysis
Data on categories were reported as the  number of patients (percentage of 
the  appropriate group). As most of the  quantitative variables were non-normally 
distributed (according to Shapiro-Wilk’s test), we reported the  median [lower; 
upper quartile], while the  mean and standard deviation (SD) were provided for age. 
Contingency tables were analyzed with chi-squared test. Th e  diff erences between 
the  groups were assessed with Mann-Whitney’s test. Th e  correlations were assessed 
with Spearman’s rank coeffi  cient. Th e  tests were two-tailed and the  p-values ≤0.05 
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indicated statistically signifi cant results. We used Statistica 12 (StatSoft , Tulsa, OK, 
USA) for computations.
Results
Comparison of  NLR, LMR and PLR values 
between patients with and without organ failure
Th e study group included 95 patients: 65 (68%) men and 30 (32%) women. Mean 
(SD) age of the  study group was 48 (17) years. During the  fi rst week of AP, organ 
failure with ≥2 points in MMSS was diagnosed in nine patients. Th e baseline clinical 
characteristics of the  study patients who developed organ failure and those without 
organ failure were presented in Table 1.
Table 1. Clinical characteristics of the study group according to the score in modifi ed Marshall scoring 
system (MMSS).
Characteristic MMSS ≥2 (n = 9)
MMSS <2 
(n = 86) p-value
Male sex, n (%) 7 (78) 58 (67) 0.5
Mean age (SD), years 57 (20) 47 (16) 0.2
Pre-existing comorbidities, n (%) 4 (44) 38 (44) 0.9
Cardiac diseases, n (%) 4 (44) 26 (30) 0.4
Diabetes, n (%) 1 (11) 7 (8) 0.8
Etiology:
Biliary, n (%) 3 (33) 24 (28)
0.9
Alcoholic, n (%) 3 (33) 26 (30)
Hypertriglyceridemia, n (%) 0 5 (6)
Other/idiopathic, n (%) 3 (33) 31 (36)
Pancreatic or peripancreatic necrosis, n (%) 2 (22) 10 (12) 0.4
Median Ranson score [Q1; Q3], points 6 [5; 7] 3 [2; 4] <0.001
Median BISAP [Q1; Q3], points 3 [2; 3] 2 [2; 2] 0.022
Median duration of hospital stay
[Q1; Q3], days 15 [10; 27] 12 [8; 15] 0.5
SIRS in fi rst 24 hours, n (%) 8 (89) 66 (77) 0.4
Early/late mortality, n (%) 1 (11)/2 (22) 0/1 (1) <0.001
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Characteristic MMSS ≥2 (n = 9)
MMSS <2 
(n = 86) p-value
Th erapeutic ERCP, n (%) 2 (22) 3 (3) 0.016
Surgery, n (%) 4 (44) 4 (5) <0.001
Transfer to ICU, n (%) 5 (56) 2 (2) <0.001
Final severity
MAP, n (%) 0 29 (34)
<0.001MSAP, n (%) 4 (44) 54 (63)
SAP, n (%) 5 (56) 3 (3)
ERCP — endoscopic retrograde cholangiopancreatography; ICU — intensive care unit; MAP — mild acute 
pancreatitis; MSAP — moderately severe acute pancreatitis; n — number of patients; SAP — severe acute 
pancreatitis; SIRS — systemic infl ammatory response syndrome; SD — standard deviation; Q1 — lower 
quartile; Q3 — upper quartile.
On the  first day of observation, the  WBC counts of patients with AP were 
in the  wide range from 5.2 × 103/μL to 32.8 × 103/μL. Th ere were no statistically 
significant differences in the  total WBC counts between patients with MMSS ≥2 
points and those without organ failure (Table 2). Th e average neutrophil counts and 
percentages were higher in patients with high MMSS, while the  lymphocyte counts 
were lower, but the  differences were also statistically non-significant (Table 2). 
Th e median monocyte count in high MMSS group was twice as high as in low MMSS 
patients, however, in both groups the  variability of monocyte counts was high and 
thus the diff erence was non-signifi cant (Table 2). Th e platelet counts in both groups 
were comparable (Table 2). Th e values of NLR and PLR observed on day 1 of the study 
did not diff er signifi cantly between the groups, however, LMR was signifi cantly lower 
among the patients with MMSS ≥2 points. 
Table 2. Th e  results of laboratory tests in the  study group according to the  score in modifi ed Marshall 
scoring system (MMSS). Data are shown as median [Q1; Q3].
Characteristic MMSS ≥2(n = 9)
MMSS <2
(n = 86) p-value
WBC, ×103/μL 13.7 [9.7; 21.9] 12.4 [10.3; 15.6] 0.3
Neutrophils, ×103/μL 15.4 [8.6; 24.2] 10.3 [6.9; 14.7] 0.3
Neutrophils, % 89.5 [78.3; 92.5] 83.5 [77.9; 86.7] 0.2
Lymphocytes, ×103/μL 0.77 [0.46; 1.38] 1.16 [0.66; 1.61] 0.3
Lymphocytes, % 2.85 [2.6; 14.6] 9.3 [4.9; 13.7] 0.2
Table 1. Cont.
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Characteristic MMSS ≥2(n = 9)
MMSS <2
(n = 86) p-value
NLR 31.17 [16.77; 34.75] 8.61 [5.59; 18.49] 0.2
Monocytes, ×103/μL 1.71 [0.57; 2.0] 0.84 [0.62; 1.07] 0.3
Monocytes, % 5.2 [4.2; 9.8] 6.2 [5.3; 7.9] 0.6
LMR 0.47 [0.28; 0.57] 1.44 [0.78; 1.95] 0.033
Hemoglobin, g/dL 14.9 [14.1; 15.4] 15.4 [14; 16.7] 0.6
RBC, ×106/μL 4.68 [4.56; 4.90] 4.90 [4.46; 5.29] 0.5
Hematocrit, % 43 [41.7; 46] 43.7 [40.6; 46.5] 0.9
Platelets, ×103/μL 189 [165; 278] 204 [168.5; 261] 0.9
PLR 278.3 [138.4; 969.6] 171.5 [111.2; 253.2] 0.3
Serum amylase, U/L 492 [331; 1996] 473 [171; 1812] 0.7
Albumin, g/L 33 [26; 26] 37 [33; 41] 0.1
Total protein, g/L 69 [61; 77] 65 [63; 77] 0.8
Total calcium, mmol/L 2.05 [1.85; 2.28] 2.14 [1.98; 2.28] 0.4
Glucose, mmol/L 7.72 [6.94; 9.16] 7.44 [6.16; 9.0] 0.5
Urea, mmol/L 8.66 [5.83; 13] 4.33 [3.33; 5.83] <0.001
Creatinine, μmol/L 166.1 [86.6; 184.7] 68.1 [58.3; 84.8] <0.001
Bilirubin, μmol/L 30.9 [19.8; 49.5] 24.9 [13.8; 39.6] 0.3
AST, U/L 118 [82; 166] 91 [46; 202] 0.2
ALT, U/L 77 [54; 92] 107 [49; 243] 0.8
LDH, U/L 854 [698; 1281] 619 [498.5; 813.5] 0.07
CRP, mg/L 36.6 [14,8; 338] 25.4 [8.7; 178] 0.4
D-dimer, mg/L 3076.6 [1499.4; 4888.6] 1788.4 [883.7; 2917] 0.1
Procalcitonin, ng/mL 1.68 [0.29; 17] 0.14 [0.05; 0.36] 0.001
uPAR, ng/mL 6.73 [3.98; 7.76] 3.80 [2.90; 4.92] 0.010
Interleukin 6, pg/mL 724.7 [62.7; 1713] 72.75 [23.93; 145.5] 0.013
ALT — alanine aminotransferase; AST — aspartate aminotransferase; CRP — C-reactive protein; IL-6 — 
interleukin  6; LDH — lactate dehydrogenase; LMR — lymphocyte to monocyte ratio; NLR — neutrophil 
to lymphocyte ratio; PLR — platelet to lymphocyte ratio; RBC — red blood cells; uPAR — urokinase-type 
plasminogen activator receptor; WBC — white blood cells.
Table 2. Cont.
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On study day 2 and 3, lymphocyte counts diff ered signifi cantly between patients 
with MMSS ≥2 points and <2 points (Fig. 1). Th e  diff erences between the  groups 
in WBC and neutrophil counts became signifi cant on day 3 of the  study (Fig. 1). 
On days 2 and 3, the  diff erence in NLR between the  patients with MMSS above 
Fig. 1. WBC (A, B), neutrophil (C, D) and lymphocyte (E, F) counts on day 2 (A, C, E) and day 3 (B, D, F) 
of the  study among patients with acute pancreatitis with and without organ failure associated with two 
or more points in modifi ed Marshall scoring system (MMSS). Data are shown as median, interquartile 
range (box), non-outlier range (whiskers) and outliers (dots).
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and below 2 points was highly signifi cant (Fig. 2). As on day 1, we observed no 
diff erences between the groups in day 2 and 3 monocyte and platelet counts (p >0.4 
in all cases). Moreover, day 2 and 3 LMR and PLR values did not diff er between the 
groups (Fig. 2).
Fig. 2. NLR (A, B), LMR (C, D) and PLR (E, F) indexes on day 2 (A, C, E) and day 3 (B, D, F) of 
the  study among patients with acute pancreatitis with and without organ failure associated with two 
or more points in modifi ed Marshall scoring system (MMSS). Data are shown as median, interquartile 
range (box), non-outlier range (whiskers) and outliers (dots).
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In logistic regression analysis, NLR values assessed on day 2 and 3, as well as 
WBC, neutrophil and lymphocyte count on day 3 of the study signifi cantly predicted 
organ failure in the early phase of AP (Table 3). 
Table 3. Statistically signifi cant predictors of organ failure in the  fi rst week of acute pancreatitis 
associated with two or more points in modifi ed Marshall scoring system. Odds ratios (OR) in simple 
logistic regression analysis per 1 unit increase in the  value of predictor variable are given with 95% 
confi dence intervals (CI).
Predictor variable
Day 2 Day 3
OR (95% CI) p-value OR (95% CI) p-value
WBC, per 1 ×103/μL – – 1.28 (1.07–1.54) 0.007
Neutrophils, per 1 ×103/μL – – 1.30 (1.04–1.62) 0.017
Lymphocytes, per 1 ×103/μL – – 0.01 (0.0002–0.65) 0.028
NLR, per 1 1.15 (1.01–1.31) 0.028 1.18 (1.03–1.35) 0.016
Comparison of other laboratory markers 
between patients with and without organ failure
Among studied laboratory markers, urea, creatinine, procalcitonin, uPAR and IL-6 
concentrations were signifi cantly higher among patients with organ failure (MMSS ≥2 
points) than among those without the  complication (Table 2). Th ese diff erences 
remained statistically signifi cant throughout the  study. Moreover, on day 2 and 3, 
patients with MMSS ≥2 points presented higher concentrations of bilirubin (median 
38.9 versus 18.6 μmol/L on day 2; p = 0.029, and 35.3 versus 15.1 μmol/L on day  3; 
p = 0.019, respectively), and higher amylase activity in sera (median 590 versus 
141 U/L on day 2; p = 0.032, and 184 versus 76 U/L on day 3; p = 0.041, respectively). 
Correlations of CBC values and NLR, LMR and PLR indexes 
with IL-6, uPAR and other laboratory markers
In the  whole studied group of patients at the  early phase of AP, we observed 
signifi cant correlations between the  studied CBC values as well as the  NLR, LMR, 
and PLR indexes, and the results of laboratory tests associated with organ failure and 
infl ammation (Table 4).
WBC (on day 3), neutrophil count (on days 1 and 3), and NLR (on days 2 
and  3) correlated positively with urea concentrations, while negative correlations 
were observed between urea and lymphocyte count (on day 2) and LMR (on day 2) 
(Table 4). Monocyte count correlated positively with serum creatinine (throughout 
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the study), and there was a negative correlation between platelet count and creatinine 
on day 3. Serum bilirubin correlated positively with NLR (on day 2), and negatively 
with lymphocyte and platelet counts (on days 2 and 3). Serum lactate dehydrogenase 
activity on days 2 and 3 was positively correlated with WBC, neutrophil, monocyte 
counts and NLR and negatively with lymphocyte, platelet counts and LMR (Table 4).
Table 4. Statistically signifi cant correlations of white blood cell counts, diff erential counts, neutrophil to 
lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR) and platelet to lymphocyte ratio (PLR) 
with selected laboratory markers during early stage of acute pancreatitis.
Variable
Day 1 Day 2 Day 3
R p-value R p-value R p-value
White blood cell count
Urea – – – –  0.24 0.02
LDH – – – –  0.30 0.01
CRP  0.21 0.04  0.40 <0.001  0.50 <0.001
Procalcitonin  0.29 0.01  0.37 <0.001  0.52 <0.001
D-Dimer – –  0.34 0.001  0.46 <0.001
IL-6  0.37 <0.001  0.50 <0.001  0.59 <0.001
Ranson score – –  0.41 <0.001 – –
Absolute neutrophil count
Urea  0.42 0.004 – –  0.30 0.006
LDH – –  0.32 0.006  0.27 0.02
CRP – –  0.48 <0.001  0.55 <0.001
Procalcitonin  0.33 0.03  0.52 <0.001  0.61 <0.001
D-Dimer – –  0.45 <0.001  0.48 <0.001
uPAR – – – –  0.26 0.03
IL-6  0.42 0.006  0.63 <0.001  0.63 <0.001
Ranson score – –  0.45 <0.001 – –
NLR
Urea – –  0.37 0.001  0.33 0.003
Bilirubin – –  0.23 0.04 – –
LDH – –  0.39 <0.001  0.44 <0.001
CRP – –  0.51 <0.001  0.57 <0.001
Procalcitonin  0.51 <0.001  0.61 <0.001  0.68 <0.001
D-Dimer – –  0.40 <0.001  0.47 <0.001
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Variable
Day 1 Day 2 Day 3
R p-value R p-value R p-value
uPAR  0.36 0.03  0.34 0.002  0.40 <0.001
IL-6  0.53 <0.001  0.53 <0.001  0.64 <0.001
Ranson score – –  0.29 0.008 – –
Absolute lymphocytes count
Urea – – –0.28 0.01 – –
Bilirubin – – –0.37 <0.001 –0.26 0.02
LDH – – –0.25 0.03 –0.37 0.001
CRP – – –0.28 0.01 –0.26 0.01
Procalcitonin –0.40 0.007 –0.38 <0.001 –0.41 <0.001
uPAR –0.34 0.03 –0.42 <0.001 –0.38 <0.001
IL-6 –0.29 0.06 –0.27 0.006 –0.29 0.009
Absolute monocyte count
Creatinine  0.37 0.01  0.24 0.03  0.29 0.01
LDH – – – –  0.40 <0.001
CRP – – – –  0.45 <0.001
Procalcitonin  0.38 0.01 – –  0.41 <0.001
D-Dimer – – – –  0.46 <0.001
uPAR – – – –  0.27 0.02
IL-6 – – – –  0.53 <0.001
LMR
Urea – – –0.26 0.02 – –
LDH – – –0.28 0.01 –0.28 0.02
CRP – – –0.33 0.003 –0.29 0.01
Procalcitonin –0.52 <0.001 –0.33 0.004 –0.37 0.001
D-Dimer – – –0.32 0.005 – –
uPAR –0.35 0.04 –0.26 0.02 – –
IL-6 –0.50 0.001 –0.30 0.009 –0.32 0.005
Platelet count
Bilirubin – – –0.46 <0.001 –0.41 <0.001
LDH – – –0.32 0.006 – –
Table 4. Cont.
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Variable
Day 1 Day 2 Day 3
R p-value R p-value R p-value
Creatinine – – – – –0.23 0.03
CRP –0.20 0.06 – – – –
PLR
Procalcitonin – – – – 0.24 0.03
uPAR – – 0.23 0.04 – –
IL-6 – – – – 0.25 0.02
ALT — alanine aminotransferase; AST — aspartate; CRP — C-reactive protein; IL-6 —  interleukin 6; LDH 
— lactate dehydrogenase; LMR — lymphocyte to monocyte ratio; NLR — neutrophil to lymphocyte ra-
tio; PLR — platelet to lymphocyte ratio; uPAR — urokinase-type plasminogen activator  receptor; WBC — 
white blood cells.
Th e studied laboratory markers of infl ammation correlated positively with WBC, 
neutrophil count, NLR, monocyte count, and PLR, and negatively with lymphocyte 
count, and LMR (Table 4). Total WBC counts and NLR values were signifi cantly 
associated with CRP, procalcitonin and IL-6 throughout the study, and with D-dimer 
on days 2 and 3. Moreover, NLR positively correlated with serum uPAR during 
the  entire observation period. Neutrophil counts significantly correlated with 
procalcitonin and IL-6 throughout the  study, with CRP and D-dimer on days  2 
and 3 and with uPAR on day 3. Lymphocyte counts were negatively associated with 
uPAR, IL-6 and procalcitonin on days 1 to 3, and with CRP on days 2 and 3. Only 
day 3 monocyte counts correlated with the  studied infl ammatory markers, except 
for correlation with procalcitonin on day 1, while more significant correlations 
were observed for LMR (Table 4). In case of platelet counts, only a  weak negative 
correlation with CRP was observed on day 1, while PLR positively correlated with 
uPAR (on day 2), procalcitonin and IL-6 (on day 3) (Table 4).
Moreover, significant correlations were observed between Ranson’s score and 
WBC, neutrophil, count and NLR (Table 4).
Discussion
Th e increase in peripheral blood neutrophil counts and the  decrease in lymphocyte 
counts is commonly observed in patients with SIRS developing in the course of various 
diseases, including AP, severe septic complications, bacteremia, as a  consequence of 
extensive surgical injury or aft er a cardiothoracic surgery [1, 8, 11, 13, 14]. It has been 
proposed previously that monitoring the values of NLR can be more useful than total 
WBC counts in diff erentiating between the  mild and severe AP [14]. In the  course 
Table 4. Cont.
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of AP neutrophils propagate infl ammation and tissue injury via the  activation of 
a wide range of mediators and infl ammatory markers i.e. proinfl ammatory cytokines 
(IL-6, IL-8, tumor necrosis factor a), proteolytic enzymes (elastase, myeloperoxidase, 
collagenase) and reactive oxygen species. In turn, lymphopenia in the  fi rst 24  hours 
can be an independent marker of progression of infl ammation, necrosis and 
septic complications and it remains a  negative prognostic factor in this group of 
patients  [1,  8, 11]. Shen et al. [11] revealed that reduced lymphocyte count within 
48 hours from AP onset refl ects the dysfunction of the immune system and might be 
an early and eff ective predictor of pancreatic necrosis [11].
Th e present study showed that in patients with vital organ failure in the  early 
phase of AP (MMSS ≥2 points in the  fi rst week of AP), lower absolute lymphocyte 
counts were observed on days 2 and 3 from the onset of AP symptoms in comparison 
to patients without organ failure. Th e  lymphocyte counts observed in patients with 
organ failure were, in fact, below the lower reference limit of 1.0 to 5.0 ×103/μL already 
on day 1 of AP. Simultaneously, in the  whole studied group, we observed absolute 
neutrophilia and increased NLR index as compared to the  previously reported 
reference values (1.8 to 8.0 ×103/μL and 0.78 to 3.53, respectively) [15, 16]. NLR on 
days 2 and 3 from AP onset signifi cantly predicted vital organ failure developing in 
the fi rst week of the disease.
The widely available automated 5-diff hematological analyzers can provide 
28  diagnostic parameters which in the  case of WBC differentiate their 5 main 
populations i.e. neutrophils, lymphocytes, monocytes, eosinophils, and basophils. 
Th e wide panel of red blood cell indexes may be used for the evaluation of anemia. 
The  extended flagging system enables the  identification of almost 30 various 
abnormalities regarding the  CBC result [16]. The  recommendations established 
in 1992 by the  National Committee for Clinical Laboratory Standards [currently 
functioning under the  name of Clinical and Laboratory Standards Institute (CLSI)] 
advocated for the  use of absolute cell counts instead of percentages of white blood 
cells subpopulations, in consequence of wide availability of automated blood cell 
counters. Th is was a  signifi cant shift  in the  interpretation of CBC results that also 
enabled the  use of indexes such as NLR, LMR, or PLR in the  routine medical 
diagnostics [16]. At present, the  values of NLR, PLR, and LMR indexes can be 
easily obtained following ordering an automated CBC with WBC diff erential. Th eir 
availability in everyday clinical practice depends solely on the  laboratory’s decision 
to include them in the  diagnostic panel by implementing the  simple formulas for 
their mathematical computation. Th is wide availability encouraged us to analyze 
the  indexes in association with more sophisticated laboratory markers such as IL-6 
and uPAR with respect to early prediction of organ failure in AP.
We observed signifi cantly lower LMR values on day 1. Th e  result is in line with 
the  study by Li et al. [9], which showed that LMR index has a  minor prognostic 
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value in SAP prediction. LMR index, however, has not been yet carefully studied 
in AP, and the  most abundant research on its prognostic value concerns primarily 
colorectal cancer [17], pancreatic cancer [18–20], hematological malignancies  [21] 
and breast cancer [22]. The  mentioned studies pointed to correlations between 
the LMR values and the degree of systemic infl ammation, as well as progression-free 
and overall survival. The  significantly higher NLR values on days 2 and 3 in 
patients with complicated course of AP are also in accordance with the  previous 
observations [3, 8, 12, 14]. Th e work by Cho et al. [3] as the only one highlights clearly 
higher NLR and PLR indexes values in patients with biliary etiology of SAP  [3]. In 
2011, Azab et al. [14] found that the  NLR >4.7 allows for an accurate prognosis of 
SAP and the necessity to transfer patients to intensive care unit [6, 12, 14]. Our study 
did not confi rm the observations regarding PLR, including those of Kaplan et al.  [6] 
who showed significantly higher values of PLR index in patients with severe or 
complicated course of AP [6].
In our study, NLR values strongly positively correlated with procalcitonin and 
IL-6 concentrations and also positively correlated with serum uPAR during the whole 
observation time. Moreover, it correlated with several markers of organ dysfunction 
(urea, bilirubin, lactate dehydrogenase) and the values of Ranson’s score. A statistically 
signifi cant inverse correlation was observed between LMR and both procalcitonin 
and IL-6 on all days of the study as well as with uPAR on days 1 and 2. Our previous 
studies on diagnostic usefulness of IL-6 in the early phase of AP demonstrated that it 
is useful for prediction of severe course of AP [23]. IL-6 is one of the cytokines which 
fi rst reaches the infl ammation site and is produced by a wide array of cells: monocytes, 
T-cells, B-cells, neutrophils, fi broblasts and also pancreatic acinar cells [23,  24]. In 
prediction of SAP, it has been shown to complement the SIRS criteria  [24]. As IL-6 
is not available in most routine diagnostic laboratories, NLR may be considered as 
a surrogate marker in the early phase of AP. 
uPAR, in turn, is a glycoprotein expressed on various cells, including monocytes, 
macrophages, neutrophils, endothelial cells and some cancer cells [25]. uPAR  and 
its urokinase-type plasminogen activator ligand play an important role in the
immunological response linked with migration, adhesion, angiogenesis, fi brinolysis, 
and cell proliferation [26]. Th e  increase in serum concentrations of the soluble form 
of the  receptor has been linked with the  activation of the  immunological system 
and refl ects the severity of infl ammatory diseases. In the present study, we observed 
signifi cantly higher concentrations of uPAR among the patients with vital organ failure 
starting from day 1 from the onset of AP symptoms. Signifi cant positive correlations 
were observed between uPAR and NLR as well as negative correlations with absolute 
lymphocyte counts on each study day. Moreover, LMR negatively correlated with 
uPAR on two first days of the  study. Previously, uPAR has been associated with 
the severity of AP as well as other acute states [7, 27], thus its correlation with NLR 
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can additionally justify the need for the evaluation of NLR values in the daily clinical 
practice.
Conclusions
Since the  computation of indexes: NLR, LMR and PLR is easily attainable based on 
routine CBC with WBC diff erential, incorporating them into routine diagnostics 
has been suggested. Constantly increased values of NLR observed in the  fi rst three 
days following the onset of AP in the patients who developed early organ failure and 
the  correlations of NLR with more sophisticated infl ammatory markers (including 
uPAR and IL-6) point to the potential usefulness of this index in the early prognosis 
of the severe course of AP. 
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